Literature DB >> 35507302

Immunohistochemical Profile of Polymorphous Adenocarcinoma of Minor Salivary Gland: A Systematic Review and Meta-Analysis.

Taichiro Nonaka1, Hidehiro Takei2.   

Abstract

Polymorphous adenocarcinoma (PAC) is a rare variant of minor salivary gland tumors. Because of its architectural diversity, histological diagnosis of PAC can be difficult especially for small biopsies, and immunohistochemistry is of great help in differentiating it from its histologic mimics. The aim of this study is to conduct a systematic literature review to identify reliable immunohistochemical markers for PAC. We conducted an electronic literature search of the MEDLINE, ScienceDirect, SpringerLink, and Wiley Online Library databases, covering the literature published in the period between 1988 and 2021. The eligibility criteria included case reports and retrospective studies of PAC cases with details of immunohistochemical markers. Following the search and selection process, 32 studies with 409 cases were included in this systematic review. Overall, > 90% positivity was observed for pan-cytokeratin (CK) (97.3%), CK7 (96.8%), CK7/8 (97.4%), E-cadherin (90.0%), Vimentin (92.5%), S100 (97.0%), p63 (91.7%), and SOX10 (100%), while little to no positivity was observed for CK20 (0.0%), p40 (0.0%), and GFAP (5.0%). The average MIB-1 labeling index was 3.78%. The results of this systematic review indicate that CK7+/CK20-, p63+/p40-, S100+, Vimentin+, and GFAP- immunophenotype have diagnostic value for PAC. In addition, the use of S100, MSA, p40, and c-Kit provide additional layers of information helpful to differentiate PAC from adenoid cystic carcinoma, one of challenging differential diagnoses.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenoid cystic carcinoma; Diagnostic marker; Immunohistochemistry; Polymorphous adenocarcinoma; Salivary gland tumor

Year:  2022        PMID: 35507302     DOI: 10.1007/s12105-022-01453-6

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  43 in total

1.  Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma.

Authors:  R H Simpson; T J Clarke; P T Sarsfield; P G Gluckman; A V Babajews
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

2.  Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy.

Authors:  V Araújo; S Sousa; M Jaeger; R Jaeger; A Loyola; M Crivelini; N Araújo
Journal:  Oral Oncol       Date:  1999-03       Impact factor: 5.337

3.  Cellular differentiation and morphologic heterogeneity in polymorphous low-grade adenocarcinoma of minor salivary gland.

Authors:  L E Norberg; A P Burford-Mason; I Dardick
Journal:  J Oral Pathol Med       Date:  1991-09       Impact factor: 4.253

4.  Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study.

Authors:  J A Regezi; R J Zarbo; J C Stewart; R M Courtney
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-04

5.  Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands.

Authors:  A Skálová; R H Simpson; H Lehtonen; I Leivo
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

6.  Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

Authors:  Nilufer Avci; Adem Deligonul; Sahsine Tolunay; Erdem Cubukcu; Omer Fatih Olmez; Arife Ulas; Mustafa Hartavi; Ender Kurt; Turkkan Evrensel
Journal:  J BUON       Date:  2015 Jan-Feb       Impact factor: 2.533

7.  Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm.

Authors:  H L Evans; J G Batsakis
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

8.  Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study.

Authors:  D R Gnepp; J C Chen; C Warren
Journal:  Am J Surg Pathol       Date:  1988-06       Impact factor: 6.394

9.  Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation.

Authors:  B Perez-Ordonez; I Linkov; A G Huvos
Journal:  Histopathology       Date:  1998-06       Impact factor: 5.087

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.